First Mercantile Trust’s RAPT Therapeutics RAPT Stock Holding History

First Mercantile Trust’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$69K	Buy	280 +7	+3%	+$1.85K	0.01%	737
2021 Q2	$69K	Sell	273 -35	-11%	-$6.54K	0.01%	761
2021 Q1	$55K	Sell	308 -38	-11%	-$6.26K	0.01%	771
2020 Q4	$55K	Sell	346 -30	-8%	-$6.52K	0.01%	781
2020 Q3	$96K	Sell	376 -26	-6%	-$5.77K	0.01%	687
2020 Q2	$93K	Buy	+402	New	+$62.2K	0.01%	695

Other funds holding RAPT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

KXA

KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Mercantile Trust's RAPT Position: Q3 2021 in Review

First Mercantile Trust increased its RAPT Therapeutics (RAPT) stake by 2.6% in Q3 2021, buying an estimated $1.85K and bringing the position to 280 shares worth $69K. The position accounts for 0.01% of the portfolio, ranked #737.

First Mercantile Trust first reported a position in RAPT in Q2 2020 and has held it in 6 quarters since. The position peaked at $96K in Q3 2020. 106 funds tracked by Wall St. Rank hold RAPT as of Q3 2021.

First Mercantile Trust held 280 shares of RAPT Therapeutics worth $69K as of Q3 2021.
First Mercantile Trust bought 7 RAPT Therapeutics shares in Q3 2021, an estimated $1.85K.
RAPT Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #737 holding.
First Mercantile Trust first reported a position in RAPT Therapeutics in Q2 2020 and has held it in 6 quarters since.
First Mercantile Trust's RAPT Therapeutics position peaked at $96K in Q3 2020.
106 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.